Unique genomic profile of fibrolamellar hepatocellular carcinoma.
about
Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developmentsCIViC databaseFibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular CarcinomaGenome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.Protein kinase A catalytic subunit isoform PRKACA; History, function and physiologyScreening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cellsMethylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features.A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy.Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.A genomic case study of mixed fibrolamellar hepatocellular carcinomaCancer Prevention: Obstacles, Challenges and the Road Ahead.YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersCopy number variation in archival melanoma biopsies versus benign melanocytic lesions.Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers.Exosomal transfer of vasorin expressed in hepatocellular carcinoma cells promotes migration of human umbilical vein endothelial cells.Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis.Viral hepatitis and liver cancer.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Molecular testing for the clinical diagnosis of fibrolamellar carcinoma.Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.
P2860
Q26746583-F192F73A-8830-4262-81D6-547AC6CB2D32Q27612411-262E6F71-C4FB-465E-A984-74AFFE58CB90Q28072292-2802E43C-CA4F-4856-A47B-03A8CC0C61BCQ33652971-CAEBE58F-286E-4E11-8E3F-72A4A872808DQ34505964-0D095147-8BBC-4861-A9D7-DD51B467DACDQ36000994-A76028A5-DBF8-42C5-A033-ECD01249D748Q36145871-533AD6A0-89C4-4177-AEAA-04F54E23C0B4Q36212867-F7F8DAF6-3A96-4F85-860A-41B94C6E75E8Q36502944-2CD673CC-707F-4020-B02B-C81C61D88FB3Q36731897-CED80762-FBD8-4A0A-A1BD-64CA8E2FB371Q36935210-272B9F4F-A76F-4876-8D36-11FFDBA26525Q37002946-A1B6471E-9E12-4886-B21A-2E397416DFD3Q37239849-2E834065-ACEF-4A0A-8CD0-9975DDA8A886Q37631655-5D888242-7387-416B-A8F1-6548DD091AFFQ38381518-29047497-FC37-4160-8D61-BE2710A9EAEBQ38724218-B161A845-DC08-4ADD-B189-74A1427469B5Q38855159-6224BBB5-87A2-4286-920A-5A0A55396FDFQ38901483-0362AD5A-BC3D-4264-8072-FDED4B614CE8Q38974653-02F955F6-FAD6-4035-8D8A-A68E77249543Q40046596-66E8440C-EACF-4479-A50D-EB10B1B2CB7BQ41670848-90B69C5C-ECF2-4368-BFDF-919748E5D4C9Q46447893-063888C3-1D06-4458-A900-8C171EC10754Q46545465-F4FF1B2D-7DDA-4E16-957C-7E5A82B60A0CQ47377422-89E87C02-6EFB-4B27-B323-29DEDA61F6C3Q47635386-2D486473-06C1-4AF2-A46F-DE73E21FA4B6Q48095053-96CE05BD-1AEE-4D45-B67B-8C5E940696CEQ52689575-42C675C0-E1EA-4118-A1B0-CD1DD5BB4796Q54237690-6F280363-A1A1-4BD2-B394-BD4C746BA864
P2860
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@ast
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@en
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@nl
type
label
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@ast
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@en
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@nl
altLabel
Unique Genomic Profile of Fibrolamellar Hepatocellular Carcinoma
@en
prefLabel
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@ast
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@en
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@nl
P2093
P2860
P50
P3181
P1433
P1476
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
@en
P2093
Alberto Quaglia
Anja Lachenmayer
Clara Alsinet
David M Nagorney
Flair Carrilho
Helena Cornella
Laia Cabellos
Leonardo Rodriguez-Carunchio
Myron Schwartz
P2860
P304
806-18.e10
P3181
P356
10.1053/J.GASTRO.2014.12.028
P407
P50
P577
2015-04-01T00:00:00Z